Author(s):
Chandra Sekhar Naik. D, Shaik Abdul Rehman, Shaik Jafar Ali, K. Uday Kiran, Md. Zulekha
Email(s):
chandu.desavath@gmail.com
DOI:
10.52711/0974-360X.2025.00471
Address:
Chandra Sekhar Naik. D*, Shaik Abdul Rehman, Shaik Jafar Ali, K. Uday Kiran, Md. Zulekha
Nimra College of Pharmacy, Jupudi, Ibrahimpatnam, NTR -AP-521456.
*Corresponding Author
Published In:
Volume - 18,
Issue - 7,
Year - 2025
ABSTRACT:
The mucilage from Plantago ovata is being explored as a novel, highly effective disintegrating component in the creation of rapidly dissolving tablets for drugs that are not easily soluble, due to its enhanced compatibility with living systems and its attraction to water. This research aims to evaluate the immediate and delayed toxicity levels of Plantago ovata mucilage in Wistar rats. In the initial phase, the mucilage was given to Wistar rats in a single dose over a period of seven days. For the subsequent phase, both sexual Wistar rats have being subjected to a twenty-eight days study to evaluate the effects of oral dosages ranging from 50 to 600 milligrams per kilogram of body weight daily on various parameters including body mass, aliment consumption, death rates, biochemical tests, and histological examinations. The initial study showed that the highest dose of Plantago ovata mucilage that did not cause death in rats was above 2000 milligrams per kilogram of body mass. The follow-up study on subacute toxicity did not reveal any significant differences in contrast to the group under supervision, and there were no alterations in blood or biochemical levels. The pancreatic, kidneys, and liver weights were also consistent. From these results, it was determined that Plantago ovata mucilage at a dosage of 2000 mg/kg body mass daily was not chimeric or weakening, and did not affect reproduction or development, suggesting it is generally safe for oral consumption.
Cite this article:
Chandra Sekhar Naik. D, Shaik Abdul Rehman, Shaik Jafar Ali, K. Uday Kiran, Md. Zulekha. Short Term-Subacute and Chronic Toxicity Studies on The Mucilage of Plantago ovata, A Novel Natural Compound Administered by Oral in Wistar Rats. Research Journal of Pharmacy and Technology. 2025;18(7):3268-2. doi: 10.52711/0974-360X.2025.00471
Cite(Electronic):
Chandra Sekhar Naik. D, Shaik Abdul Rehman, Shaik Jafar Ali, K. Uday Kiran, Md. Zulekha. Short Term-Subacute and Chronic Toxicity Studies on The Mucilage of Plantago ovata, A Novel Natural Compound Administered by Oral in Wistar Rats. Research Journal of Pharmacy and Technology. 2025;18(7):3268-2. doi: 10.52711/0974-360X.2025.00471 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-7-51
REFERENCES:
1. Haddadian K, Haddadian K and Zahmatkash M. A review of Plantago plant. Indian Journal of Traditional Knowledge. 2014; 13 (4): 681-685
2. Chiang-Lienchai, Chiang-Wen, Chang-Meiyin, Lin-Chunching. In vitro cytotoxic, antiviral and immunomodulatory effects of Plantago major and Plantago asiatica. Amercian Journal of Chinese-Medicine. 2003; 31(2): 225-234.
3. Celik T.A. and Aslanturk O.S. Antimitotic and antigenotoxic effects of Plantago lanceolata aqueous extracts on Allium cepa root tip meristem cells. Biologia. 2006; 61: 693-697.
4. Fahmy S, Abu-Gharbieh E. In vitro dissolution and in vivo bioavailability of six brands of ciprofloxacin tablets administered in rabbits and their pharmacokinetic modelling. Biomed Res Int. 2014 :590848. https://doi: 10.1155/2014/590848.
5. Fernández M, Sepúlveda J, Aránguiz T, von Plessing C. Technique validation by liquid chromatography for the determination of acyclovir in plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 ;791(1-2):357-63. https://doi: 10.1016/s1570-0232(03)00252-6.
6. Bhar K, Mondal S, Seru G. Acute and Sub-Acute Toxicity Studies of Dhatupaushtik Churna. Trop J Nat Prod Res. 2021; 5(10): 1760-1765.
7. Mamidi RN, Chaluvadi MR, Benjamin B, Ramesh M, Katneni K, Babu AP, Bhanduri J, Rao NM, Rajagopalan R. HPLC method for the determination of rosiglitazone in human plasma and its application in a clinical pharmacokinetic study. Arzneimittelforschung. 2002; 52(7): 560-4. https://doi: 10.1055/s-0031-1299930.
8. Eldin AS, Azab SM, Shalaby A, El-Maamly M. The development of a new validated HPLC and spectrophotometric methods for the simultaneous determination of daclatasvir and sofosbuvir: antiviral drugs. Journal of Pharmacy and Pharmacology Research. 2017; 1(1): 28-42. https://doi:10.26502/jppr.0004
9. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008; 22(3): 659-61. https://doi: 10.1096/fj.07-9574LSF.
10. Babu GN, Menaka M, Ahad HA. Neem Fruit Mucilage-Aided Mucoadhesive Microspheres of Acyclovir Using 32 Factorial Design With Design-Expert Software. Applied Biological Research. 2022; 24 (1): 17-27. https://doi: 10.5958/0974-4517.2022.00001.5
11. Anonymous (2000) OECD Guidelines for the Testing of Chemicals, Revised Draft Guidelines423: Acute Oral toxicity-Acute Toxic Class Method, Revised Document. Govt. of India: CPCSEA, Ministry of Social Justice and Empowerment.